Lepu (Shenzhen) International Development Center Co., Ltd.

Lepu International is an international development center established in Shenzhen by the Lepu Group. Currently, the international center encompasses several subsidiaries, including Shenzhen Zhongke Lepu Medical Technology Co., Ltd. and Shenzhen Lepu Smart Medical Devices Co., Ltd. Lepu (Beijing) Medical Devices Co., Ltd. was founded in 1999 and is headquartered in Changping Park, Zhongguancun Science Park, Beijing. The company is a Sino-foreign joint venture high-tech enterprise engaged in the research and development, production, and sales of cardiovascular interventional diagnostic and therapeutic devices and equipment, such as coronary drug-eluting stents, congenital heart occluders, heart valves, and angiography machines, as well as cardiovascular pharmaceuticals. It was one of the first 28 companies listed on the ChiNext board of the Shenzhen Stock Exchange in 2009, and in November 2014, it was selected as one of the 50 sample stocks of the CCTV Finance 50 Index for 2014. The company currently has 8 domestic and overseas subsidiaries. Its products are clinically applied in over 1,200 cardiac diagnosis and treatment centers nationwide. It has developed into a high-end medical product industry group for cardiovascular interventional diagnostic and therapeutic devices, equipment, and pharmaceuticals, and has initially established a full cardiovascular industry chain platform integrating devices, pharmaceuticals, services, and mobile healthcare.